Report an error
Spotted something inaccurate in “High Tumor Immune Infiltration Associated with Greater Benefit from BRAF-Targeted Therapy in Melanoma”? Tell us what’s wrong and we’ll check it against the original source.
This form is for factual corrections. We read every report but cannot reply individually.